- $135.81m
- $162.90m
- $127.83m
Annual income statement for DHI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 120 | 150 | 152 | 142 | 128 |
| Cost of Revenue | |||||
| Gross Profit | 105 | 132 | 132 | 122 | 108 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 122 | 146 | 146 | 136 | 140 |
| Operating Profit | -1.75 | 3.26 | 5.99 | 5.92 | -12.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.03 | 3.6 | 3.62 | 2.95 | -14.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.402 | 4.18 | 3.49 | 0.253 | -13.5 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -29.7 | 4.18 | 3.49 | 0.253 | -13.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.7 | 4.18 | 3.49 | 0.253 | -13.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.046 | 0.128 | 0.163 | 0.054 | 0.105 |